Instil Bio, Inc.
Developing autologous TIL cell therapies using a patient's own immune cells to fight solid tumors.
TIL | NDAQ
Overview
Corporate Details
- ISIN(s):
- US45783C2008
- LEI:
- Country:
- United States of America
- Address:
- 3963 MAPLE AVENUE, 75219 DALLAS
- Website:
- https://instilbio.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Instil Bio, Inc. is a clinical-stage biopharmaceutical company focused on the development of novel cell therapies for cancer. The company specializes in creating a pipeline of autologous tumor-infiltrating lymphocyte (TIL) therapies, which utilize a patient's own immune cells to target and combat solid tumors. Instil Bio is dedicated to advancing its therapeutic candidates through clinical trials to provide innovative treatment options for patients.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Instil Bio, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Instil Bio, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Instil Bio, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
